Abstract
Kava (Piper methysticum Forst. f., Piperaceae), prepared as the traditional aqueous infusion, was tested in the rat for possible effects on liver function tests. Extracts were administered in daily dosages of 200 or 500 mg of the active kavalactones/kg for two or four weeks. Sera were assayed for four enzymes that are markers of liver toxicity and liver homogenates for malondialdehyde formation that indicates changes in lipid peroxidation. The data showed that none of the enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and lactate dehydrogenase, nor malondialdehyde were elevated, in fact in some cases they were significantly reduced, suggesting the lack of a toxic effect by kava on the liver.
References
-
1
Singh Y N.
Kava: an overview.
J Ethnopharmacol.
1992;
37
13-45
-
2 Lebot V, Merlin M, Lindstrom L. Kava. The Pacific Elixir. Rochester, VT; Healing Arts Press 1997: pp. 1-9
-
3
Singh Y N, Singh N N.
Therapeutic potential of kava in the treatment of anxiety disorders.
CNS Drugs.
2002;
16
731-43
-
4 Schmidt J. Analysis of kava side effects. Reports concerning the liver. Lindenmaier M, Brinckmann J, translators Unpublished report. 2001; courtesy. Silver Springs, MD; American Herbal Products Association
-
5
M M WR.
Hepatic toxicity possibly associated with kava-containing products - United States, Germany, and Switzerland, 1999 - 2002. Morbidity and Mortality Weekly Report.
Centers for Disease Control and Prevention, Atlanta, GA.
2002;
51 (47)
1065-7
-
6 Waller D P. Report on kava and liver Damage. Silver Springs, MD; American Herbal Products Association 2002
-
7
Schmidt M, Nahrstedt A.
Ist Kava lebertoxisch?.
Dtsch Apoth Ztg.
2002;
9
1006-11
-
8 Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C W, Rister R S. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicine. Austin, Texas; American Botanical Council 1998: pp. 156-7
-
9
Zou L, Harkey M R, Henderson G L.
Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.
Life Sci.
2002;
71
1579-89
-
10
Unger M, Holzgrabe U, Jacobsen W, Cummins C, Benet L Z.
Inhibition of cytochtome P450 3A4 by extracts and kavalactones of Piper methysticum (kava-kava).
Planta Medica.
2002;
68
1055-8
-
11
Mathews J M, Etheridge A S, Black S R.
Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
Drug Metab Dispos.
2002;
30
1153-7
-
12
Poolsup N, Po L, Knight T.
Pharmacogenetics and psychopharmacotherapy.
J Clin Pharmacol Ther.
2002;
5
197-220
-
13
Wanwimolruk S, Bhawan S, Coville P F, Chalcroft S C.
Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations.
Eur J Clin Pharmacol.
1998;
54
431-5
-
14
El-Demerdash F M.
Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats.
J Environ Sci Health.
2001;
36
489-99
-
15
Lebot V, Johnston E, Zheng Q Y, McKern D, McKenna D J.
Morphological, phytochemical, and genetic variation in Hawaiian cultivars of ‘awa (Kava, Piper methysticum, Piperaceae).
Economic Botany.
1999;
53
407-18
-
16
Smith R M, Thakrar H, Arowolo T A, Shafi A A.
High-performance liquid chromatography of kava lactones from Piper methysticum
.
J Chromatogr.
1984;
283
303-86
-
17
Lebot V, Lévesque J.
Evidence of cospecificity of Piper methysticum Forst. and Piper wichmannii C. DC.
Biochem System Ecol.
1996;
24
775-82
-
18
Dharmaratne H RW, Nanayakkara N PD, Khan I A.
Kavalactones from Piper methysticum and their 13C-NMR spectroscopic analyses.
Phytochemistry.
2002;
59
429-33
-
19 Faustman E M, Omenn G S. Risk assessment. In: Klaasen CD, editor Casarett and Doull’s Toxicology. The Basic Science of Poisons. 6th edition. New York; McGraw Hill 2001: pp. 83-104
-
20
Lebot V, Lévesque J.
The origin and distribution of kava (Piper methysticum Forst. f., Piperaceae): a phytochemical approach.
Allertonia.
1989;
5
223-81
-
21
Ganzera M, Khan I A.
Analytical techniques for the determination of lactones in Piper methysticum Forst.
Chromatographia.
1999;
50
649-53
-
22
Lee V, Randhawa A K, Singal P K.
Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals.
Am J Physiol.
1991;
261(Heart Circ Physiol 30)
H989-995
Dr. Yadhu N. Singh
College of Pharmacy
South Dakota State University
Brookings
South Dakota 57007-0099
USA
Phone: +1-605-688-4239
Fax: +1-605-688-6232
Email: Yadhu_Singh@sdstate.edu
